These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3038500)

  • 21. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
    Senft HH; Stiglmayer R; Eibach HW; Koerner H
    Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
    Wexler HM; Harris B; Carter WT; Finegold SM
    Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of sulbactam/ampicillin in humans: a review.
    Foulds G
    Rev Infect Dis; 1986; 8 Suppl 5():S503-11. PubMed ID: 3025997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
    Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV; Reines HD; Hunt P
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of sulbactam and ampicillin into peritoneal fluid.
    Wise R; Donovan IA; Andrews JM; Drumm J; Bennett S
    Antimicrob Agents Chemother; 1983 Aug; 24(2):290-2. PubMed ID: 6314889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
    Wald E; Reilly JS; Bluestone CD; Chiponis D
    Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
    Plouffe JF
    Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children.
    Ginsburg CM; McCracken GH; Olsen K; Petruska M
    J Antimicrob Chemother; 1985 Mar; 15(3):345-51. PubMed ID: 2987174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with ampicillin/sulbactam in severe infections.
    Kanra G
    J Int Med Res; 2002; 30 Suppl 1():20A-30A. PubMed ID: 11921491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.
    Emmerson AM; Cox DA; Lees LJ
    Eur J Clin Microbiol; 1983 Aug; 2(4):340-4. PubMed ID: 6313357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
    Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
    Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulbactam: a beta-lactamase inhibitor.
    Noguchi JK; Gill MA
    Clin Pharm; 1988 Jan; 7(1):37-51. PubMed ID: 3278833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV; Botta GA; Pesce A; Schito GC
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
    Retsema JA; English AR; Girard AE
    Antimicrob Agents Chemother; 1980 Apr; 17(4):615-22. PubMed ID: 6249192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.